160 related articles for article (PubMed ID: 31386979)
1. Antiviral activity of merimepodib against foot and mouth disease virus in vitro and in vivo.
Li SF; Gong MJ; Shao JJ; Sun YF; Zhang YG; Chang HY
Mol Immunol; 2019 Oct; 114():226-232. PubMed ID: 31386979
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Molecules; 2019 May; 24(9):. PubMed ID: 31058822
[TBL] [Abstract][Full Text] [Related]
3. Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro.
Zhao FR; Xie YL; Liu ZZ; Shao JJ; Li SF; Zhang YG; Chang HY
J Med Virol; 2017 Nov; 89(11):2041-2046. PubMed ID: 28390158
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of homoharringtonine on foot and mouth disease virus in vitro.
Gong MJ; Li SF; Xie YL; Zhao FR; Shao JJ; Zhang YG; Wang WH; Chang HY
J Med Virol; 2019 Sep; 91(9):1595-1601. PubMed ID: 31032977
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Biomed Pharmacother; 2019 Aug; 116():108982. PubMed ID: 31146110
[TBL] [Abstract][Full Text] [Related]
6. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effect of amiloride on replication of foot and mouth disease virus in cell culture.
Gong MJ; Chang YY; Shao JJ; Li SF; Zhang YG; Chang HY
Microb Pathog; 2019 Oct; 135():103638. PubMed ID: 31326561
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD).
Jeong KW; Lee JH; Park SM; Choi JH; Jeong DY; Choi DH; Nam Y; Park JH; Lee KN; Kim SM; Ku JM
Eur J Med Chem; 2015 Sep; 102():387-97. PubMed ID: 26301555
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of selected IMPDH and DHODH inhibitors against foot and mouth disease virus.
Mei-Jiao G; Shi-Fang L; Yan-Yan C; Jun-Jun S; Yue-Feng S; Ting-Ting R; Yong-Guang Z; Hui-Yun C
Biomed Pharmacother; 2019 Oct; 118():109305. PubMed ID: 31545264
[TBL] [Abstract][Full Text] [Related]
10. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.
Goris N; De Palma A; Toussaint JF; Musch I; Neyts J; De Clercq K
Antiviral Res; 2007 Mar; 73(3):161-8. PubMed ID: 17055073
[TBL] [Abstract][Full Text] [Related]
11. Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
Kim Y; Pool E; Kim E; Dampalla CS; Nguyen HN; Johnson DK; Lovell S; Groutas WC; Chang K-O
Microbiol Spectr; 2024 Apr; 12(4):e0337223. PubMed ID: 38466127
[TBL] [Abstract][Full Text] [Related]
12. Grouper (Epinephelus coioides) antimicrobial peptide epinecidin-1 exhibits antiviral activity against foot-and-mouth disease virus in vitro.
Huang HN; Pan CY; Chen JY
Peptides; 2018 Aug; 106():91-95. PubMed ID: 30012343
[TBL] [Abstract][Full Text] [Related]
13. Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and invivo.
Lee G; Kang HR; Kim A; Park JH; Lee MJ; Kim SM
Antiviral Res; 2022 Sep; 205():105384. PubMed ID: 35863499
[TBL] [Abstract][Full Text] [Related]
14. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
[TBL] [Abstract][Full Text] [Related]
15. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Effect of Manganese against Foot-and-Mouth Disease Virus Both in PK15 Cells and Mice.
Zhang Z; Zhang R; Yin J; Zhao S; Qin X; Chen F; Yang Y; Bai L; Guo Z; Wu Y; Li Y; Zhang Z
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851604
[TBL] [Abstract][Full Text] [Related]
17. The Kinase STK3 Interacts with the Viral Structural Protein VP1 and Inhibits Foot-and-Mouth Disease Virus Replication.
Liu H; Xue Q; Zeng Q; Zhu Z; Zheng H
Biomed Res Int; 2017; 2017():2481348. PubMed ID: 29226127
[TBL] [Abstract][Full Text] [Related]
18. Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents.
Kim SM; Park JH; Lee KN; Kim SK; Ko YJ; Lee HS; Cho IS
Antiviral Res; 2012 Nov; 96(2):213-20. PubMed ID: 23000495
[TBL] [Abstract][Full Text] [Related]
19. A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.
De Vleeschauwer AR; Lefebvre DJ; Willems T; Paul G; Billiet A; Murao LE; Neyts J; Goris N; De Clercq K
Transbound Emerg Dis; 2016 Apr; 63(2):e205-12. PubMed ID: 25164494
[TBL] [Abstract][Full Text] [Related]
20. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N
Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
